Kenneth Carleton Frazier (born (1954-12-17)December 17, 1954) is an American business executive. He is the chairman and CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America). After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first black man to lead a major pharmaceutical company (part of the Fortune 500 companies). He was elected to the American Philosophical Society in 2018.